4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-037761
CSO, Head Res.&Non-Clin. Dev. sold 48,368 shares at $24.34 ($1,177,277)
- CSO, Head Res.&Non-Clin. Dev. acquired 48,368 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kavanaugh William Michael · CSO, Head Res.&Non-Clin. Dev.
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-10-04 | Exercise or conversion : show line 1 in the form | +48,368 | $4.47 | $216,340 | 62,285 | D |
| 2017-10-04 | Sale : show line 2 in the form | −48,368 | $24.34 | $1,177,277 | 13,917 | D |
| Open-market sales · 48,368 sh · avg $24.34 · $1,177,277 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-10-04 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −48,368 | 48,368 | D |
Loading xslF345X03/doc1.xml…